CHARACTERIZATION OF PRESCRIBING PATTERN IN THE MANAGEMENT OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS IN A TERTIARY CARE HOSPITAL

被引:0
作者
Rao, K. Harsha Vardhan [1 ]
Ijitha, S. [1 ]
Sowmya, M. [1 ]
Yaidikar, Lavanya [1 ]
机构
[1] Seven Hills Coll Pharm, Tirupati 517502, Andhra Prades, India
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2018年 / 5卷 / 06期
关键词
Prescription patterns; Rheumatoid arthritis; Osteoarthritis;
D O I
10.5281/zenodo.1295598
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objectives: Osteoarthritis (OA), a progressive disorder characterized by destruction of articular cartilage with synovial changes. Rheumatoid arthritis (RA), a systemic inflammatory and autoimmune disease characterized by synovial inflammation, autoantibody production and joint space narrowing. Drugs like non-steroidal anti-inflammatory drugs (NSAIDs), symptomatic slow acting drugs (SYSADOA) disease modifying anti-rheumatic drug (DMARDs), steroids etc are using widely in OA and RA therapy. A prescribing pattern study analyzes the trend of prescribing drugs, its rationality and provides feedback to the prescribers. We aimed to study the prescription patterns in OA and RA therapy through a prospective observational analysis. Methodology: We studied 100 outpatients for six months between June 2017 - December 2017. We reviewed prescriptions and analysed the patterns. Results: Out of 100 patients, 35% were with OA and 65% were RA. 25% are males and 75% are females. OA and RA were more prevalent in the age groups of 51-60 years (45.7%) and 41-50 years (35.4%) respectively. Out of 239 prescribed drugs, Aceclofenac (26.31%) and Naproxen (26.31%) were the first choice of drugs in OA patients and Methotrexate (25.4%) for RA. Of the patient total, 14.3% were treated in monotherapy and 85.7% received two or more drugs. Conclusion: We found combinational therapy (SYSADOA+NSAIDs & DMARDs) was more often than monotherapy in OA and RA. We also found the prescribed drugs are rational and are in essential drug list.
引用
收藏
页码:5466 / 5471
页数:6
相关论文
共 21 条
  • [1] Alunno A, 2015, MEDIAT INFLAMM, P751
  • [2] Anjali C, 2016, INT J PHARM PHARM SC, V6, P170
  • [3] Osteoarthritis: Epidemiology
    Arden, N
    Nevitt, MC
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (01): : 3 - 25
  • [4] Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
    Bianchi, Gerolamo
    Caporali, Roberto
    Todoerti, Monica
    Mattana, Paolo
    [J]. ADVANCES IN THERAPY, 2016, 33 (03) : 369 - 378
  • [5] Bishnoi M., 2006, Indian Journal of Pharmaceutical Sciences, V68, P525
  • [6] Anti-inflammatory effect of corymbocoumarin from Seseli gummiferum subsp corymbosum through suppression of NF-κB signaling pathway and induction of HO-1 expression in LPS-stimulated RAW 264.7 cells
    Chun, Jaemoo
    Tosun, Alev
    Kim, Yeong Shik
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 31 : 207 - 215
  • [7] Anti-arthritic activity of Indian monocellate cobra (Naja kaouthia) venom on adjuvant induced arthritis
    Gomes, Antony
    Bhattacharya, Sourav
    Chakraborty, Mousumi
    Bhattacharjee, Pushpak
    Mishra, Roshnara
    Gomes, Aparna
    [J]. TOXICON, 2010, 55 (2-3) : 670 - 673
  • [8] Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
    Helmick, Charles G.
    Felson, David T.
    Lawrence, Reva C.
    Gabriel, Sherine
    Hirsch, Rosemarie
    Kwoh, C. Kent
    Liang, Matthew H.
    Kremers, Hilal Maradit
    Mayes, Maureen D.
    Merkel, Peter A.
    Pillemer, Stanley R.
    Reveille, John D.
    Stone, John H.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 15 - 25
  • [9] Advances in research on animal models of rheumatoid arthritis
    Hu, Yiping
    Cheng, Wenxiang
    Cai, Wenhong
    Yue, Ye
    Li, Jinchao
    Zhang, Peng
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (02) : 161 - 165
  • [10] Immanuel JM, 2015, INDO AM J PHARM SCI, V2, P1198